AR020587A1 - Metodo para la profilaxis o tratamiento de una infeccion bacteriana en mamiferos, uso de un inhibidor de oxido nitrico sintasa inducible para lafabricacion de medicamentos y formulacion farmaceutica - Google Patents
Metodo para la profilaxis o tratamiento de una infeccion bacteriana en mamiferos, uso de un inhibidor de oxido nitrico sintasa inducible para lafabricacion de medicamentos y formulacion farmaceuticaInfo
- Publication number
- AR020587A1 AR020587A1 ARP990102245A ARP990102245A AR020587A1 AR 020587 A1 AR020587 A1 AR 020587A1 AR P990102245 A ARP990102245 A AR P990102245A AR P990102245 A ARP990102245 A AR P990102245A AR 020587 A1 AR020587 A1 AR 020587A1
- Authority
- AR
- Argentina
- Prior art keywords
- prophylaxis
- manufacture
- treatment
- nitrical
- injibitor
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940119568 Inducible nitric oxide synthase inhibitor Drugs 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente describe el uso de un inhibidor de la oxido nítrico sintasa inducible para la fabricacion de un medicamento para la profilaxis o tratamiento deinfecciones bacterianas donde el inhibidor de la oxido nítrico sintasa inducible es, por ejemplo un compuesto de formula (1) o una sal, éster o amidafarmacéuticamente aceptable del mismo, en la cual R1 es un grupo alquilo C1-6 de cadena lineal o ramificada; y R2 es un grupo de formula (2) o (3), lossustituyentes R3, y Q, tienen los significados que constan en la descripcion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810299.9A GB9810299D0 (en) | 1998-05-15 | 1998-05-15 | Use of nitric oxide synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020587A1 true AR020587A1 (es) | 2002-05-22 |
Family
ID=10832007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102245A AR020587A1 (es) | 1998-05-15 | 1999-05-12 | Metodo para la profilaxis o tratamiento de una infeccion bacteriana en mamiferos, uso de un inhibidor de oxido nitrico sintasa inducible para lafabricacion de medicamentos y formulacion farmaceutica |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR020587A1 (es) |
| AU (1) | AU4040699A (es) |
| GB (1) | GB9810299D0 (es) |
| MA (1) | MA24854A1 (es) |
| PE (1) | PE20000474A1 (es) |
| WO (1) | WO1999059566A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0031179D0 (en) | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Nitric oxide synthase inhibitors |
| AU2003232148A1 (en) * | 2002-05-16 | 2003-12-02 | Pharmacia Corporation | A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases |
| US7838532B2 (en) | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| DK2346509T3 (da) | 2008-10-07 | 2020-08-03 | Horizon Orphan Llc | Inhalation af levofloxacin til at reducere lungeinflammation |
| BRPI0920026B1 (pt) | 2008-10-07 | 2023-11-07 | Horizon Orphan Llc | Composição farmacêutica e respectivos usos |
| IN2012DN02477A (es) | 2009-09-04 | 2015-08-21 | Mpex Pharmaceuticals Inc | |
| DE102010055322A1 (de) * | 2010-12-21 | 2012-06-21 | Christian-Albrechts-Universität Zu Kiel | Antibakteriell und antimykotisch wirkende Substanzen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312835A (en) * | 1989-09-13 | 1994-05-17 | Board Of Regents, The University Of Texas System | Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| US5545625A (en) * | 1994-12-12 | 1996-08-13 | The Medical College Of Wisconsin Research Foundation, Inc. | Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction |
| GB9425701D0 (en) * | 1994-12-20 | 1995-02-22 | Wellcome Found | Enzyme inhibitors |
| MY117948A (en) * | 1997-01-13 | 2004-08-30 | Glaxo Group Ltd | Nitride oxide synthase inhibitors. |
| GB9702312D0 (en) * | 1997-02-05 | 1997-03-26 | Univ London | Method for identifying selective inhibitors of nitric oxide synthase |
-
1998
- 1998-05-15 GB GBGB9810299.9A patent/GB9810299D0/en not_active Ceased
-
1999
- 1999-05-05 MA MA25569A patent/MA24854A1/fr unknown
- 1999-05-12 AU AU40406/99A patent/AU4040699A/en not_active Abandoned
- 1999-05-12 PE PE1999000395A patent/PE20000474A1/es not_active Application Discontinuation
- 1999-05-12 AR ARP990102245A patent/AR020587A1/es unknown
- 1999-05-12 WO PCT/EP1999/003265 patent/WO1999059566A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| PE20000474A1 (es) | 2000-06-06 |
| MA24854A1 (fr) | 1999-12-31 |
| GB9810299D0 (en) | 1998-07-15 |
| WO1999059566A1 (en) | 1999-11-25 |
| AU4040699A (en) | 1999-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
| MX23619A (es) | Derivados de aminoacidos y procedimiento para su preparacion y medicamento que lo contiene. | |
| EA200501098A1 (ru) | Антибактериальные агенты | |
| CY1111061T1 (el) | Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων | |
| BR9813835A (pt) | Composto, composição farmacêutica e método de tratamento ou prevenção de uma desordem tromboembólica | |
| DK0715623T3 (da) | Blodpladeaggregationsinhibitorer | |
| PA8485601A1 (es) | Azalidas de 13 miembros y su uso como agentes antibioticos. | |
| NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
| AR020587A1 (es) | Metodo para la profilaxis o tratamiento de una infeccion bacteriana en mamiferos, uso de un inhibidor de oxido nitrico sintasa inducible para lafabricacion de medicamentos y formulacion farmaceutica | |
| SE9701304D0 (sv) | Compounds | |
| DK0659193T3 (da) | Blodpladeaggregationsinhibitorer | |
| AR025379A1 (es) | 9a-azalidas con actividad antibacteriana. | |
| AR029001A1 (es) | Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento | |
| PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
| AR021463A1 (es) | Antibiotico de piridona con perfil de seguridad mejorado | |
| ES2191763T3 (es) | Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico. | |
| BR0313683A (pt) | Pró-droga inibidora de beta-lactamase | |
| TH1701007800A (th) | ตัวยับยั้งเมทัลโล-บีตา-แลคทาเมส | |
| DK0774969T3 (da) | HIV-proteaseinhibitor kombination | |
| SE9802650D0 (sv) | Compounds | |
| BR0307468A (pt) | Derivados tiadiazinona antimicrobianos úteis no tratamento de infecções bacterianas | |
| AR126702A1 (es) | Compuestos fosfolípidos y métodos de preparación y uso de los mismos | |
| DK1065206T3 (da) | Tetrazolylalkylindol-forbindelser som anti-inflammatoriske og analgetiske midler | |
| ATE158503T1 (de) | Aids-virus-infektion hemmende zusammensetzung | |
| ECSP900707A (es) | Derivados de aminoacidos |